RxDoctor Payments Data

Christopher Clark, APRN

Family · Lexington, KYNPI 1649641895

Payments from drug & device makers

$1,389in general payments, 2019–2025

Across 78 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$284
  • Lilly USA, LLC$138
  • Exact Sciences$89
  • Collegium Pharmaceutical, Inc.$87
  • Axsome Therapeutics, Inc.$87
  • Novo Nordisk$83
  • plus $621 from 21 others

What the payments were for

  • Food & beverage$1,389100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,389 in reported general payments places this provider in the 70th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$22,434
Medicare patients
67
Services billed
310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin23$38,447
JanuviaSitagliptin Phosphate21$24,136
EliquisApixaban18$18,194
MounjaroTirzepatide13$17,440
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$4,988
SymbicortBudesonide/Formoterol Fumarate13$3,062
Fluticasone-SalmeterolFluticasone Propion/Salmeterol23$1,878
Atorvastatin Calcium219$1,505
Albuterol Sulfate HfaAlbuterol Sulfate65$1,237
SynthroidLevothyroxine Sodium20$1,071
Gabapentin45$1,015
Levothyroxine Sodium100$861
Amitriptyline Hcl18$796
NovologInsulin Aspart11$779
Duloxetine Hcl26$712

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$17$18,19418 claims
Lilly USA, LLCMounjaro$138$17,44013 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$15$861100 claims
Novo NordiskNovolog$83$77911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,374 family providers in Kentucky.

Other family in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →